ÌÇÐÄvlog

This randomized clinical trial examines the relative efficacy of weight-adjusted d-cycloserine (25 or 50 mg) vs placebo augmentation of cognitive behavior therapy for youth with obsessive-compulsive disorder and assesses if concomitant antidepressant medication moderated effects.

This randomized clinical trial tests whether whole-body hyperthermia has specific antidepressant effects when compared with a sham treatment.

This study uses Swedish national registry data to identify triggers for violent behavior in patients with schizophrenia spectrum and bipolar disorders, and to compare risk in those populations vs healthy controls.

This nonrandomized trial compares the effects of an intervention comprising manual-guided sessions on health care engagement and health information technology use vs usual care on self-reported substance use and depression.

This meta-analysis examines whether behavioral deficits in inhibitory control are associated with shared or disorder-specific structural and functional neural abnormalities in attention-deficit/hyperactivity disorder and obsessive-compulsive disorder.

This meta-analysis of randomized and observational studies reports comparison of neonatal outcomes among women with untreated antenatal depression vs no depression.

This longitudinal study examines the association of long-term marijuana use in young adults with the response of the nucleus accumbens to award anticipation.

This longitudinal prospective study uses data from the Nurses’ Health Study to examine the association between religious service attendance and suicide and the joint associations of suicide with service attendance and religious affiliation.

This cross-sectional study examines whether common risk variants for psychosis are associated with individual variation in the ventral striatum.

This case-control study examines whether the pattern of brain connectivity across striatal subregions is abnormal in unmedicated patients with schizophrenia and whether this abnormality relates to psychotic symptoms and extrastriatal dopaminergic transmission.